Download PDF
Hamostaseologie 1986; 06(06): 254-262
DOI: 10.1055/s-0038-1655172
Originalarbeiten
Schattauer GmbH

Faktor V: Biochemische Eigenschaften und die Funktion des Kofaktors bei der Regulation der Thrombinbildung

P. van de Waart
1   Klinische Forschungsgruppe für Blutgerinnung und Thrombose, Max-Planck-Gesellschaft, Gießen
› Author Affiliations
Further Information

Publication History

Publication Date:
25 June 2018 (online)

Also available at
    Permissions and Reprints

 

 

  • Literatur

  • 1 Bangham AD. A correlation between surface charge and coagulant action of phospholipids. Nature 1961; 192: 1197-8.
    CrossrefPubMedGoogle Scholar
  • 2 Barton PG, Findly EJ. In: The Significance of Platelet Function Tests in the Evolution of Haemostatic and Thrombosis Tendencies. Day HJ, Zucker MB, Hornsen M. (eds). Bethesda Md: US Natl Inst Health; 1977: 462-70.
    Google Scholar
  • 3 Baruch D, Hemker HC, Lindhout T. Kinetics of thrombin induced release and activation of platelet factor V. Eur J Biochem 1986; 154: 213-8.
    CrossrefPubMedGoogle Scholar
  • 4 Bevers EM, Comfurius P, van Ryn J L M L, Hemker HC, Zwaal RFA. Generation of prothrombin converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 1982; 122: 429-36.
    CrossrefPubMedGoogle Scholar
  • 5 Bloom JW, Nesheim ME, Mann KG. Phospholipid-binding properties of bovine factor V and factor Va. Biochemistry 1979; 18: 4419-25.
    CrossrefPubMedGoogle Scholar
  • 6 Breederveld K, Giddings JC, TenCate JW, Bloom AL. The localization of Factor V within normal human platelets and the demonstration of a platelet factor V antigen in congenital factor V deficiency. Br J Haematol 1975; 29: 405-12.
    CrossrefPubMedGoogle Scholar
  • 7 Bull RK, Jerson S, Barton PG. Complexes of prothrombin with calcium ions and phospholipids. J Biol Chem 1972; 247: 2747-54.
    PubMedGoogle Scholar
  • 8 Chesney CM, Pifer D, Colman RW. Subcellular localization and secretion of factor V from human platelets. Proc Natl Acad Sci USA 1981; 781: 5180-4.
    PubMedGoogle Scholar
  • 9 Cerveny TJ, Fass DN, Mann KG. Synthesis of coagulation factor V by cultured aortic endothelium. Blood 1984; 63: 1467-74.
    PubMedGoogle Scholar
  • 10 Chiu HC, Schick PK, Colman RW. Biosynthesis of factor V in isolated guinea pig megakariocytes. J Clin Invest 1985; 75: 339-46.
    CrossrefPubMedGoogle Scholar
  • 11 Church WR, Jernigan RL, Tool J, Hewick RM, Knopf J, Knutson GJ, Nesheim ME, Mann KG, Fass DN. Coagulation factors V and VIII and ceruloplasmin constitute a family of structural related proteins. Proc Natl Acad Sci USA 1984; 81: 6934-7.
    CrossrefPubMedGoogle Scholar
  • 12 Dahlbäck B. Ultrastructure of human coagulation factor V. J Biol Chem 1985; 260: 1347-9.
    PubMedGoogle Scholar
  • 13 Dahlbäck B, Nilsson JM, Frohm B. Inhibition of platelet prothrombinase activity by a lupus anticoagulant. Blood 1983; 62: 218-25.
    PubMedGoogle Scholar
  • 14 Dahlbäck B, Stenflo J. Inhibitory effect of activated protein C on activation of prothrombin by platelet-bound factor Xa. Eur J Biochem 1980; 107: 331-5.
    PubMedGoogle Scholar
  • 15 Dahlbäck B, Stenflo J. Binding of bovine coagulation factor Xa to platelets. Biochemistry 1978; 17: 4938-45.
    CrossrefPubMedGoogle Scholar
  • 16 Davie EW, Ratnoff OD. Waterfall sequence for intrinsic blood clotting. Science 1964; 145: 1310-2.
    CrossrefPubMedGoogle Scholar
  • 17 Deutsch E, Johnson SA, Seegers WH. Differentiation of certain platelet factors related to blood coagulation. Circulation Research 1955; 03: 110-5.
    CrossrefPubMedGoogle Scholar
  • 18 DiScipio RG, Davie EW. Characterization of protein S, a gammacarboxy glutamic acid containing protein from bovine and human plasma. Biochemistry 1979; 18: 899-904.
    CrossrefPubMedGoogle Scholar
  • 19 Dombrose FA, Gitel SN, Zawalich K, Jackson CM. The association of bovine prothrombin fragment 1 with phospholipid. Quantitative characterization of the Ca2+ ionmediated binding of prothrombin fragment 1 to phospholipid vesicles and a molecular model for its association with pospholipids. J Biol Chem 1979; 254: 5027-40.
    PubMedGoogle Scholar
  • 20 Enfield DL, Ericsson LE, Walsh KA, Neurath H, Titani K. Bovine factor X (Stuart factor), primary structure of the light chain. Proc Natl Acad Sci USA 1975; 72: 16-9.
    CrossrefPubMedGoogle Scholar
  • 21 Esmon CT, Owen WG, Duinquid DL, Jackson CM. The action of thrombin and blood clotting factor V: conversion of factor V to a prothrombin binding protein. Biochim Biophys Acta 1973; 310: 289-94.
    CrossrefPubMedGoogle Scholar
  • 22 Esmon CT. The subunit structure of thrombin-activated factor V. Isolation of activated factor V, separation of subunits and reconstruction of biological activity. J Biol Chem 1979; 254: 964-73.
    PubMedGoogle Scholar
  • 23 Esmon CT, Owen WG, Jackson CM. The conversion of prothrombin to thrombin. J Biol Chem 1974; 249: 7798-807.
    PubMedGoogle Scholar
  • 24 Esmon NL, Owen WG, Esmon CT. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 1982; 257: 859-64.
    PubMedGoogle Scholar
  • 25 Fair DS, Marlar RA, Levin EG. Human endothelial cells synthesize protein S. Blood 1986; 67: 1168-71.
    PubMedGoogle Scholar
  • 26 Fass DN, Hewick RM, Knutson GJ, Nesheim ME, Mann KG. Internal duplication and sequence homology in factors V and VIII. Proc Natl Acad Sci USA 1985; 82: 1688-91.
    CrossrefPubMedGoogle Scholar
  • 27 Fulcher CA, Gardenier JE, Griffin JH, Zimmerman TS. Proteolytic inactivation of human factor VIII procoagulant protein by activated protein C and its analogy with factor V. Blood 1984; 63: 486-9.
    PubMedGoogle Scholar
  • 28 Guinto ER, Esmon CT. Loss of prothrombin and of factor Xa-factor Va interactions upon inactivation of factor Va by activated protein C. J Biol Chem 1984; 259: 3986-92.
    PubMedGoogle Scholar
  • 29 Govers-Riemslag JWP, Speyer H, Zwaal RFA, Rosing J. The effects of fragment 1 and fragment 1.2 on prothrombin activation. Thromb Res 1985; 38: 375-88.
    CrossrefPubMedGoogle Scholar
  • 30 Hagglund U, Blombäck M. Amidolytic assay of factor V in human plasma. Thromb Res 1986; 41: 79-88.
    PubMedGoogle Scholar
  • 31 Hemker HC, Esnouf MP, Hemker PW, Swart ACW, MacFarlane RG. Formation of prothrombin converting activity. Nature 1967; 215: 248-51.
    CrossrefPubMedGoogle Scholar
  • 32 Higgins DL, Callahan PJ, Prendergast FG, Nesheim ME, Mann KG. Lipid mobility in the assembly and expression of the activity of the prothrombinase complex. J Biol Chem 1985; 260: 3604-12.
    PubMedGoogle Scholar
  • 33 Higgins DL, Mann KG. The interaction of bovine factor V and factor V-derived peptides with phospholipid vesicles. J Biol Chem 1983; 258: 6503-8.
    PubMedGoogle Scholar
  • 34 Ittyerah TR, Rawalla R, Colman RW. Immunochemical studies of factor V of bovine platelets. Eur J Biochem 1981; 120: 235-41.
    CrossrefPubMedGoogle Scholar
  • 35 Jackson CM, Nemerson Y. Blood coagulation. Ann Rev Biochem 1980; 49: 765-811.
    CrossrefPubMedGoogle Scholar
  • 36 Jobin F, Esnouf MP. Studies on the formation of the prothrombin-converting complex. Biochem J 1967; 102: 666-74.
    CrossrefPubMedGoogle Scholar
  • 37 Jones ME, Lentz BR, Dombrose FA, Sandberg H. Comparison of the abilities of synthetic and platelet derived membranes to enhance thrombin formation. Thromb Res 1985; 39: 711-24.
    CrossrefPubMedGoogle Scholar
  • 38 Kahn MJP, Hemker HC. Studies on blood coagulation factor V. I. The interaction of salts of fatty acids and coagulation factors. Thromb Diath Haemorrh 1969; 22: 417-30.
    PubMedGoogle Scholar
  • 39 Kane WH, Lindhout T, Jackson CM, Majerus PW. Factor Va dependent binding of factor Xa to human platelets. J Biol Chem 1980; 255: 1170-4.
    PubMedGoogle Scholar
  • 40 Kane WH, Majerus PW. Purification and characterization of human coagulation factor V. J Biol Chem 1981; 256: 1002-7.
    PubMedGoogle Scholar
  • 41 Kane WH, Majerus PW. The interaction of human coagulation factor Va with platelets. J Biol Chem 1982; 257: 3963-9.
    PubMedGoogle Scholar
  • 42 Kane WH, Mruk J, Majerus PW. Activation of coagulation factor V by a platelet protease. J Clin Invest 1982; 70: 1092-100.
    CrossrefPubMedGoogle Scholar
  • 43 Kisiel W. Human plasma protein C: isolation, characterization and mechanism of activation by thrombin. J Clin Invest 1979; 64: 761-9.
    CrossrefPubMedGoogle Scholar
  • 44 Kisiel W, Canfield WM. Snake venom proteases that activate blood coagulation factor V. Meth Enzym 1981; 80: 275-302.
    PubMedGoogle Scholar
  • 45 Kisiel W, Canfield WM, Ericsson LH, Davie EW. Anticoagulant properties of bovine plasma protein C following activation by thrombin. Biochemistry 1977; 16: 5824-31.
    CrossrefPubMedGoogle Scholar
  • 46 Kisiel W, Ericsson LH, Davie EW. Proteolytic activation of protein C from bovine plasma. Biochemistry 1976; 15: 4893-900.
    CrossrefPubMedGoogle Scholar
  • 47 Lampe PD, Pusey ML, Wei GJ, Nelsestuen GL. Electron microscopy and hydrodynamic properties of blood clotting factor V and activation fragments of factor V with phospholipid vesicles. J Biol Chem 1984; 259: 9959-64.
    PubMedGoogle Scholar
  • 48 Laue TM, Johnson AE, Esmon CT, Yphantis DA. Structure of bovine blood coagulation factor Va. Determination of the subunit associations, molecular weights, and asymmetries by analytical ultracentrifugation. Biochemistry 1984; 23: 1339-48.
    CrossrefPubMedGoogle Scholar
  • 49 Laue TM, Yphantis DA, Esmon CT, Johnson AE. The structure of factor Va and its dependence upon calcium. Circulation 1982; 66 II, 51.
    PubMedGoogle Scholar
  • 50 Lindhout T, Govers-Giemslag JWP, van de Waart P, Hemker HC, Rosing J. Factor Va-factor Xa interaction. Effects of phospholipid vesicles of varying composition. Biochemistry 1982; 21: 4594-5502.
    PubMedGoogle Scholar
  • 51 MacFarlane R G. An enzyme cascade in the blood clotting mechanism and its function as a biochemical amplifier. Nature 1964; 202: 498-9.
    CrossrefPubMedGoogle Scholar
  • 52 McLaughry R I, Seegers W H. Prothrombin, thromboplastin, AC globulin and platelet accelerator: quantitative interrelationships. Blood 1950; 05: 303-12.
    PubMedGoogle Scholar
  • 53 Mammen E F. Protein C und S. Hämostaseologie 1984; 04: 138-47.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 54 Mazzorna M, Carnillon B, Belleville J, Paul J, Eloy R. Immunolocalization of factor V in adult and fetal rat liver. Thromb Res 1985; 40: 807-16.
    CrossrefPubMedGoogle Scholar
  • 55 Miletich J P, Jackson C M, Majerus P W. Interaction of coagulation factor Xa with human platelets. Proc Natl Acad Sei USA 1977; 74: 4033-6.
    CrossrefPubMedGoogle Scholar
  • 56 Mosesson M W, Nesheim M E, Diorio J, Hainfeld J F, Wall J S, Mann K G. Studies on the structure of bovine factor V by scanning transmission electron microscopy. Blood 1985; 65: 1158-62.
    PubMedGoogle Scholar
  • 57 Nelsestuen G L. Interactions of vitamin Kdependent proteins with calcium ions and phospholipid membranes. Fed Proc 1978; 37: 2621-5.
    PubMedGoogle Scholar
  • 58 Nesheim M E, Eid S, Mann K G. Assembly of the prothrombinase complex in the absence of prothrombin. J Biol Chem 1981; 256: 9874-82.
    PubMedGoogle Scholar
  • 59 Nesheim M E, Foster W B, Hewick R, Mann K G. Characterization of factor V activation intermediates. J Biol Chem 1984; 259: 3187-96.
    PubMedGoogle Scholar
  • 60 Nesheim M E, Katzmann J A, Tracy P B, Mann K G. Factor V. Methods < Enzymol 1981; 80: 249-74.
    PubMedGoogle Scholar
  • 61 Nesheim M E, Mann K G. Thrombincatalyzed activation of single chain bovine factor V. J Biol Chem 1979; 254: 1326-34.
    PubMedGoogle Scholar
  • 62 Nesheim M E, Myrmel K H, Hibbard L, Mann K G. Isolation and characterization of single chain bovine factor V. J Biol Chem 1979; 254: 508-17.
    PubMedGoogle Scholar
  • 63 Nesheim M E, Taswell J B, Mann K G. The contribution of bovine factor V and factor Va to the activity of prothrombinase. J Biol Chem 1979; 254: 10952-62.
    PubMedGoogle Scholar
  • 64 Nolf P. Contribution a l’étude de la coagulation du sang les facteurs primordiaux, leur origine. Arc Inst Physiol 1908; 06: 1-72.
    PubMedGoogle Scholar
  • 65 Osterud B, Rapaport S I, Lavine K K. Factor V activity in platelets. Evidence for an activated factor V molecule and for a platelet activator. Blood 1977; 49: 819-34.
    PubMedGoogle Scholar
  • 66 Owren P A. The coagulation of blood. Investigations of a new clotting factor. Acta Med Scand (Suppl. 194) 1947; 1-327.
    PubMedGoogle Scholar
  • 67 Papahadjapoulos D, Hanahan D J. Observations on the interaction of phospholipids and certain clotting factors in prothrombin activator formation. Biochim Biophys Acta 1964; 90: 436-9.
    CrossrefPubMedGoogle Scholar
  • 68 Preissner K T, Miiller-Berghaus G. Molekulare Wechselwirkungen zwischen Komplement-, Gerinnungsund Fibrinolysesystem. Hämostaseologie 1986; 06: 67-81.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 69 Pusey M L, Mayer L D, Wei G J, Bloofield V A, Nelsestuen G L. Kinetic and hydrodynamic analysis of blood clotting factor V-membrane binding. Biochemistry 1982; 21: 5262-9.
    CrossrefPubMedGoogle Scholar
  • 70 Pusey M L, Nelsestuen G L. The physical significance of Km in the prothrombinase reaction. Biochem Biophys Res Com 1983; 114: 526-32.
    CrossrefPubMedGoogle Scholar
  • 71 Pusey M L, Nelsestuen G L. Membrane binding properties of blood coagulation factor V and derived peptides. Biochemistry 1984; 23: 6202-10.
    CrossrefPubMedGoogle Scholar
  • 72 Quick A J. On the constitution of prothrombin. Am J Physiol 1943; 148: 112-20.
    PubMedGoogle Scholar
  • 73 Resnich R M, Nelsestuen G L. Prothrombin-membrane interaction. Effects of ion strength, pH, and temperature. Biochemistry 1980; 19: 3028-33.
    CrossrefPubMedGoogle Scholar
  • 74 Rodgers G M, Kane W H. Activation of endogenous factor V by a homocystine induced vascular endothelial cell activator. J Clin Invest 1986; 77: 1909-18.
    CrossrefPubMedGoogle Scholar
  • 75 Rosing J, Bevers E M, Comfurius P, Hemker H C, van Dieyen G, Weiss H J, Zwaal R F. Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in a patient with a bleeding disorder. Blood 1985; 65: 1557-61.
    PubMedGoogle Scholar
  • 76 Rosing J, Tans G, Govers-Riemslag J W P, Zwaal R F A, Hemker H C. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 1980; 255: 274-83.
    PubMedGoogle Scholar
  • 77 Rosing J, Zwaal R F A, Tans G. Formation of meizothrombin as intermediate in factor Xa catalyzed prothrombin activation. J Biol Chem 1986; 261: 4224-8.
    PubMedGoogle Scholar
  • 78 Rothberger H, McGee M P. Generation of coagulation factor V activity by cultured rabbit alveolar macrophages. J Exp Med 1984; 160: 1880-90.
    CrossrefPubMedGoogle Scholar
  • 79 Salem H H, Broze G J, Miletich J P, Majerus P W. The light chain of factor Va contains the activity of factor Va that accelerates protein C activation by thrombin. J Biol Chem 1983; 258: 8531-4.
    PubMedGoogle Scholar
  • 80 Saraswathi S, Rawala R, Colman R W. Subnit structure of bovine factor V. Influence of proteolysis during blood collection. J Biol Chem 1978; 253: 1024-9.
    PubMedGoogle Scholar
  • 81 Schmaier A H, Smith P M, Puldon A D, White J G, Colman R W. High molecular weight kininogen: Localization in the unstimulated and activated platelet and activation by a platelet calpain (S). Blood 1986; 67: 119-30.
    PubMedGoogle Scholar
  • 82 Seegers W H, Novoa E, Walz D A, Andary T J, Hassouna H I. Effects of prothrombin fragments on thrombin formation and separation from AC-globulin. Thromb Res 1976; 08: 83-97.
    PubMedGoogle Scholar
  • 83 Sinha A K, Dutta A K, Chiu H C, Stewart G J, Colman R W. Coagulant factor Xa inhibits prostacyclin formation in human endothelial cells. Role of Factor V. Arteriosclerosis 1985; 05: 244-59.
    CrossrefPubMedGoogle Scholar
  • 84 Stern D, Brett J, Harris K, Nawroth P. Participation of endothelial cells in the protein C-protein S anticoagulant pathway. The synthesis and release of protein S. J Cell Biol 1986; 102: 1971-8.
    CrossrefPubMedGoogle Scholar
  • 85 Suttie J W, Jackson C M. Prothrombin structure, activation and biosynthesis. Physiol Rev 1977; 57: 1-70.
    CrossrefPubMedGoogle Scholar
  • 86 Suzuki K, Dahlbäck B, Stenflo J. Thrombin catalyzed activation of human coagulation factor V. J Biol Chem 1982; 257: 6556-64.
    PubMedGoogle Scholar
  • 87 Suzuki K, Stenflo J, Dahlbäck B, Teodorsson B. Inactivation of human coagulation factor V by activated protein C. J Biol Chem 1983; 258: 1914-20.
    PubMedGoogle Scholar
  • 88 Tangen D, Lestrup E B, Berman H. Characterisation of clotting factors associated with blood platelets after gel filtration. Thromb Diath Haem 1973; 30: 289-98.
    PubMedGoogle Scholar
  • 89 Tracy P B, Eide L L, Bowie E J W, Mann K G. Radioimmunoassay of factor V in human plasma and platelets. Blood 1982; 60: 59-63.
    PubMedGoogle Scholar
  • 90 Tracy P B, Giles A R, Mann K G, Eide L L, Hoogendoorn H, Rivard E G. Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet factor V deficiency. J Clin Invest 1984; 74: 1221-8.
    CrossrefPubMedGoogle Scholar
  • 91 Tracy P B, Mann K G. Prothrombinase complex assembly on the platelet surface is mediated through the 74,000 dalton component of factor Va. Proc Natl Acad Sci USA 1983; 80: 2380-4.
    CrossrefPubMedGoogle Scholar
  • 92 Tracy P B, Nesheim M E, Mann K G. Coordinate binding of factor Va and factor Xa to the unstimulated platelet. J Biol Chem 1981; 256: 743-51.
    PubMedGoogle Scholar
  • 93 Tracy P B, Nesheim M E, Mann K G. Proteolytic alterations of factor Va bound to platelets. J Biochem 1983; 258: 662-9.
    PubMedGoogle Scholar
  • 94 Tuszynski G P, Walsh P N. Factor V: a platelet cytoskeletal associated protein. Haematologia 1984; 17: 67-76.
    PubMedGoogle Scholar
  • 95 Tuszynski G P, Walsh P N, Piperno J R, Koshy A. Association of coagulation factor V with the platelet cytoskeleton. J Biol Chem 1982; 257: 4557.
    PubMedGoogle Scholar
  • 96 van de Waart P, Bruis H, Hemker H C, Lindhout T. Interaction of bovine blood clotting factor Va and its subunits with phospholipid vesicle. Biochemistry 1983; 22: 2427-32.
    CrossrefPubMedGoogle Scholar
  • 97 van de Waart P, Bruis H, Hemker H C, Lindhout T. Functional properties of factor Va subunits after proteolytic alterations by activated protein C. Biochim Biophys Acta 1984; 799: 38-44.
    CrossrefPubMedGoogle Scholar
  • 98 van de Waart P, Hemker H C, Lindhout T. The interaction of prothrombin with factor Va-phospholipid complexes. Biochemistry 1984; 23: 2838-42.
    CrossrefPubMedGoogle Scholar
  • 99 van de Waart P, Visser A J W G, Hemker H C, Lindhout T. The Effect of Factor Va on Km for Prothrombin in the Prothrombinase Reaction and the Rotational Motion of Prothrombin. Thesis. 1984. University Limburg; The Netherlands: 99-112.
    Google Scholar
  • 100 van Rijn J L, Govers-Riemslag J W, Zwaal R F, Rosing J. Kinetic studies of prothrombin activation: effect of factor Va and phospholipids on the formation of the enzyme substrate complex. Biochemistry 1984; 23: 4557-64.
    CrossrefPubMedGoogle Scholar
  • 101 Vivic W J, Lages B, Weiss H J. Release of human platelet factor V is induced by both collagen and ADP and is inhibited by aspirin. Blood 1980; 56: 448-55.
    PubMedGoogle Scholar
  • 102 Walker F J, Sexton P W, Esmon C T. The inhibition of blood coagulation by activated protein C through selective inactivation of activated factor V. Biochim Biophys Acta 1979; 571: 333-42.
    CrossrefPubMedGoogle Scholar
  • 103 Walker F J. Regulation of bovine activated protein C by protein S: The role of phospholipids in factor Va inactivation. J Biol Chem 1981; 256: 1128-31.
    PubMedGoogle Scholar
  • 104 Walker F J. Regulation of activated protein C by a new protein. A possible function for bovine protein S. J Biol Chem 1980; 255: 5521-4.
    PubMedGoogle Scholar
  • 105 Ware H G, Seegers W H. Plasma accelerator globulin: partial purification, quantitative determination and properties. J Biol Chem 1948; 172: 699.
    PubMedGoogle Scholar
  • 106 Wilson D B, Salem H H, Mruk J S, Maruyama I, Majerus P W. Biosynthesis of coagulation factor V by a human hepatocellular carcinoma cell line. J Clin Invest 1984; 73: 654-8.
    CrossrefPubMedGoogle Scholar
  • 107 Zolton R P, Seegers W N. Phospholipid requirements in thrombin formation. Thromb Res 1974; 04: 437-46.
    CrossrefPubMedGoogle Scholar